TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32966714

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg or 15 mg)
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg)
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (15 mg)
Number of subjects: 8246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study: 35858870

Group type: EXPERIMENTAL
Intervention: PrAISED intervention (individually tailored physical exercises and functional activities delivered via phone or video calling)
Number of subjects: 30
Study: 33599809

Group type: EXPERIMENTAL
Intervention: 0.4-g/kg dose of alcohol
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 31
Study: 34259441

Group type: EXPERIMENTAL
Intervention: Contemplative mental training (3 or 9 months)
Number of subjects: 332
Study: 34338104

Group type: EXPERIMENTAL
Intervention: Mindfulness practice group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active control group (listening to stories)
Number of subjects: 50
Study: 33245582

Group type: EXPERIMENTAL
Intervention: CD34+ cell count >32 × 10^6/L
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CD34+ cell yield of the first apheresis >2.75 × 10^6/kg
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CD34+ cell count >2.65 × 10^6/kg
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: graft CD34+CD133+CD38− cell count >0.07 × 10^6/kg
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: graft CD3+ cell count >23.1 × 10^6/kg
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: disease status of CR I at auto-SCT
Number of subjects: 68
Study: 35449191

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 0
Study: 34366890

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) for 20 min once weekly (n = 27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-WB-EMS control group (CG, n = 27)
Number of subjects: 54
Study: 35544171

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 33933665

Group type: EXPERIMENTAL
Intervention: ML digital support platform (PRESTO) with a smartphone app for monitoring and delivering psychological interventions for anxiety and depressive symptoms.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ML predictive severity model based on cases referred to the PC mental health support programme.
Number of subjects: 0
Study: 33243032

Group type: EXPERIMENTAL
Intervention: Hydration combined with reduced glutathione
Number of subjects: 396

Group type: COMPARATOR
Intervention: Hydration alone (control)
Number of subjects: 396
Study: 34501908

Group type: EXPERIMENTAL
Intervention: Positive comment
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Negative comment
Number of subjects: 211

Group type: COMPARATOR
Intervention: No comment
Number of subjects: 211
Study: 33243812

Group type: EXPERIMENTAL
Intervention: Adapted pulmonary rehabilitation (PR) program consisting of 12 sessions of exercise and health education over 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 50
Study: 35381686

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily for 14 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cilostazol (200 mg daily for 14 days)
Number of subjects: 116
Study: 34227198

Group type: EXPERIMENTAL
Intervention: 30 g/day milled flaxseed
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 g/day milled rice
Number of subjects: 60
Study: 32873289

Group type: EXPERIMENTAL
Intervention: Intervention group with instrumented gait analysis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Care as usual without instrumented gait analysis
Number of subjects: 60
Study: 32876831

Group type: EXPERIMENTAL
Intervention: Open panoramic scanner
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Upright open scanner
Number of subjects: 160

Group type: COMPARATOR
Intervention: Short-bore scanner
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Short-bore scanner with better diagnostic performance information
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Patients with claustrophobic events
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Patients scanned in a short-bore scanner
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Noise reduction
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: More space over the head
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Overall more space
Number of subjects: 160
Study: 32436794

Group type: EXPERIMENTAL
Intervention: 1 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 3 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6

Group type: COMPARATOR
Intervention: Contralateral MC (control)
Number of subjects: 6
Study: 35259025

Group type: EXPERIMENTAL
Intervention: Extrafamilial cases (stranger and babysitter)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Stranger
Number of subjects: 292
Study: 34418968

Group type: EXPERIMENTAL
Intervention: High quality video
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Medium quality video
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Low quality video
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Errors presented in video sequences
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Increased compression depth error
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Alleged errors not shown in video sequences
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Interprofessional differences
Number of subjects: 93
Study: 32338190

Group type: EXPERIMENTAL
Intervention: Nonoperative splinting
Number of subjects: 28

Group type: COMPARATOR
Intervention: Extension-block pinning
Number of subjects: 28
Study: 36215059

Group type: EXPERIMENTAL
Intervention: Physiotherapy scoliosis-specific exercise (PSSE) - 'Schroth' exercises for 8 weeks (16 sessions)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group - waiting list
Number of subjects: 29
Study: 34006053

Group type: EXPERIMENTAL
Intervention: Ambu AuraGain (AA) group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Air-Q (AQ) group
Number of subjects: 66
Study: 32667635

Group type: EXPERIMENTAL
Intervention: No Nasogastric Tube Decompression (NGTD)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nasogastric Tube Decompression (NGTD)
Number of subjects: 111
Study: 35293364

Group type: EXPERIMENTAL
Intervention: Group Lifestyle Balance (GLB‐TBI) intervention with mHealth app
Number of subjects: 56

Group type: COMPARATOR
Intervention: Brain Health Group (BHG‐TBI) active control intervention with mHealth app
Number of subjects: 56
Study: 34977071

Group type: EXPERIMENTAL
Intervention: VST (VivaSight‐SL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: VL (Videolaryngoscopy)
Number of subjects: 48
Study: 34942227

Group type: EXPERIMENTAL
Intervention: Active DMPFC-rTMS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham DMPFC-rTMS
Number of subjects: 20
Study: 32654802

Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab
Number of subjects: 142

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 142
Study: 34865664

Group type: EXPERIMENTAL
Intervention: Ultrasonography (USG)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Standard technique
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Near-Infrared Light (NIR)
Number of subjects: 270
Study: 32282472

Group type: EXPERIMENTAL
Intervention: EE‐DCR with LOS intubation (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: EE‐DCR without LOS intubation (Group B)
Number of subjects: 0
Study: 35562681

Group type: EXPERIMENTAL
Intervention: Early discharge followed by geriatric interdisciplinary home rehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-hospital care according to a multifactorial rehabilitation program
Number of subjects: 20
Study: 34260795

Group type: EXPERIMENTAL
Intervention: Apararenone 10 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32539752

Group type: EXPERIMENTAL
Intervention: Open fenestration discectomy (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fenestration microdiscectomy (Group B)
Number of subjects: 60
Study: 36483140

Group type: EXPERIMENTAL
Intervention: Workbook plus a single MI session (WMI)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Workbook (WB)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Delayed treatment control (DT)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Quantity of cannabis use
Number of subjects: 186
Study: 32142529

Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI) with local anaesthetics
Number of subjects: 62

Group type: COMPARATOR
Intervention: Epidural analgesia (EDA)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI)
Number of subjects: 62
Study: 36316102

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (sequential taper)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (concurrent taper)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (low glucocorticoid dose)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (high glucocorticoid dose)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (long-term glucocorticoid use)
Number of subjects: 86
Study: 33675971

Group type: EXPERIMENTAL
Intervention: Arthroscopy‐assisted latissimus dorsi tendon transfer (LDT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Arthroscopy‐assisted superior capsular reconstruction (SCR)
Number of subjects: 42
Study: 32357889

Group type: EXPERIMENTAL
Intervention: Mouthwash containing Teucrium polium
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mouthwash without Teucrium polium (control)
Number of subjects: 22
Study: 36325750

Group type: EXPERIMENTAL
Intervention: Prosocial behavior
Number of subjects: 538
Study: 32154784

Group type: EXPERIMENTAL
Intervention: Ecofisio mobile app
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (traditional learning)
Number of subjects: 110
Study: 33484137

Group type: EXPERIMENTAL
Intervention: Tailored text messaging intervention (NUDGE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Attention-control condition
Number of subjects: 40
Study: 32147465

Group type: EXPERIMENTAL
Intervention: Jigsaw method of learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture-based methods
Number of subjects: 0
Study: 35491562

Group type: EXPERIMENTAL
Intervention: Higher levels of social support
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Higher levels of HF knowledge
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Better self-care
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Social support and HF knowledge
Number of subjects: 122
Study: 33849174

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Urban adolescents
Number of subjects: 257

Group type: COMPARATOR
Intervention: Rural adolescents
Number of subjects: 257
Study: 34074223

Group type: EXPERIMENTAL
Intervention: Training Program for Coping with PMS Symptoms based on IMB model
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no training program)
Number of subjects: 95
Study: 32453223

Group type: EXPERIMENTAL
Intervention: Automated pressure-adjustable orthosis (PO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional orthosis (CO)
Number of subjects: 24
Study: 36369609

Group type: EXPERIMENTAL
Intervention: Test preparation (T) 10 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reference preparation (R) 10 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both T and R preparations
Number of subjects: 60
Study: 33504589

Group type: EXPERIMENTAL
Intervention: IPCS-only recruitment (n=213)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: In-person recruitment (n=87 eligible recruited)
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: Consenting patients (n=61)
Number of subjects: 1012
Study: 32819944

Group type: EXPERIMENTAL
Intervention: Chinese Healthy Heart (CHH) diet
Number of subjects: 360

Group type: COMPARATOR
Intervention: Chinese usual diet
Number of subjects: 360
Study: 33296841

Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement mimicking normal ultradian and circadian profile
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement retaining normal circadian but abolishing ultradian rhythm
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Current best oral replacement regime (suboptimal circadian and ultradian rhythm)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement (various regimes)
Number of subjects: 15
Study: 32869125

Group type: EXPERIMENTAL
Intervention: Ravulizumab (every-eight-weeks for 26 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Eculizumab (every-two-weeks for 26 weeks)
Number of subjects: 33
Study: 34794198

Group type: EXPERIMENTAL
Intervention: Prolonged course of TXA (Group B)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prolonged course of DXM (Group C)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combination of TXA and DXM (Group D)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 162
Study: 33646727

Group type: EXPERIMENTAL
Intervention: Laughter therapy (twice a week for 6 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study: 32638456

Group type: EXPERIMENTAL
Intervention: Wide QRS-T angles
Number of subjects: 1094
Study: 36415901

Group type: EXPERIMENTAL
Intervention: Immediate intensive periodontal therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed therapy (control group)
Number of subjects: 60
Study: 32979521

Group type: EXPERIMENTAL
Intervention: Lifestyle dietary intervention
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Brain-gastric interaction
Number of subjects: 92
Study: 35397977

Group type: EXPERIMENTAL
Intervention: Abdominal-based early progressive mobilisation program (passive abdominal massage, bed-side bicycle and ambulating)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Abdominal-based early progressive mobilisation program
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 83
Study: 32726473

Group type: EXPERIMENTAL
Intervention: epistemic volition intervention
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: resolvable controversies intervention
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: both interventions
Number of subjects: 412
Study: 32490621

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate and NSAIDs (group 1)
Number of subjects: 231

Group type: COMPARATOR
Intervention: NSAIDs only (group 2)
Number of subjects: 231
Study: 35026408

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Extended-release Quetiapine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aripiprazole or Extended-release Quetiapine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: PANSS-6
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CGI-I
Number of subjects: 84
Study: 34806452

Group type: EXPERIMENTAL
Intervention: 12.5% dextrose water (DW) serum, 8.75 to 18.75 g/kg/d
Number of subjects: 90

Group type: COMPARATOR
Intervention: 10% dextrose water (DW) serum, 7 to 15 g/kg/d
Number of subjects: 90
Study: 35619571

Group type: EXPERIMENTAL
Intervention: Rational Emotive Occupational Health Coaching (REOHC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group (WLG)
Number of subjects: 0
Study: 32620149

Group type: EXPERIMENTAL
Intervention: Physical activity program with connected devices (activity tracker worn 24/7, at least three weekly walking sessions, quizzes on physical activity and nutrition) for 6 months
Number of subjects: 244

Group type: COMPARATOR
Intervention: Physical activity recommendations only
Number of subjects: 244
Study: 33389132

Group type: EXPERIMENTAL
Intervention: 2/W‐TPTD (28.2‐μg teriparatide formulation for twice‐weekly use)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1/W‐TPTD (56.5‐μg teriparatide formulation for once‐weekly use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2/W‐TPTD
Number of subjects: 0
Study: 35953409

Group type: EXPERIMENTAL
Intervention: Preoperative lanreotide (120 mg)
Number of subjects: 98
Study: 34362859

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), ten 50‐minute weekly sessions
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low‐perfectionist controls
Number of subjects: 55
Study: 36147279

Group type: EXPERIMENTAL
Intervention: Topical cyclosporin A (CsA) 0.05% for 3 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no CsA)
Number of subjects: 78
Study: 33683616

Group type: EXPERIMENTAL
Intervention: Checklist
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual approach (Control)
Number of subjects: 54
Study: 33582039

Group type: EXPERIMENTAL
Intervention: Diabetes Health Coaching (DHC)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Usual Diabetes Education (DE)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: DHC plus DE
Number of subjects: 365
Study: 32152146

Group type: EXPERIMENTAL
Intervention: Genistein capsules (50 mg/day) for 2 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 45
Study: 35221757

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 µg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33156916

Group type: EXPERIMENTAL
Intervention: Medium rMED adherence
Number of subjects: 4896

Group type: EXPERIMENTAL
Intervention: Low rMED adherence
Number of subjects: 4896

Group type: EXPERIMENTAL
Intervention: High rMED adherence
Number of subjects: 4896
Study: 34301299

Group type: EXPERIMENTAL
Intervention: 2 Hz EA
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 100 Hz EA
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 144
Study: 32093451

Group type: EXPERIMENTAL
Intervention: Day Surgery Group (DSG)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Inpatient Surgery Group (ISG)
Number of subjects: 153
Study: 33734493

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 40
Study: 33221391

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise group (MEG)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise group (VEG)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 72
Study: 34836135

Group type: EXPERIMENTAL
Intervention: Health coaching and usual care for 6 months
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 114
Study: 35841024

Group type: EXPERIMENTAL
Intervention: Virtual Intervention Treatment (VIT) - includes up to 11 virtual counseling sessions with a tobacco treatment specialist and up to 12 weeks of nicotine replacement therapy (NRT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enhanced Usual Control (EUC) - receives a referral to the NCI Quitline
Number of subjects: 49
Study: 34704720

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Erector Spinae Plane Blockade (ESPB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo subcutaneous injection
Number of subjects: 52
Study: 35840999

Group type: EXPERIMENTAL
Intervention: 12-month pantoprazole treatment arm
Number of subjects: 232

Group type: COMPARATOR
Intervention: 1-month pantoprazole treatment arm
Number of subjects: 232
Study: 33542089

Group type: EXPERIMENTAL
Intervention: Supplemental O2 (42%±7%) during exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Medical air during exercise
Number of subjects: 15
Study: 32891281

Group type: EXPERIMENTAL
Intervention: Yogic meditation (MG) for eight weeks
Number of subjects: 64
Study: 35852266

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 180

Group type: COMPARATOR
Intervention: No TENS
Number of subjects: 180
Study: 33407407

Group type: EXPERIMENTAL
Intervention: Educational program based on Theory of Planned Behavior (TPB) constructs delivered via direct training
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual training only (Control)
Number of subjects: 160
Study: 33313724

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT) for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Army Medicine's holistic Move2Health (M2H) program for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined M2H + PT in phase II for nonresponders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE) program in phase II for nonresponders
Number of subjects: 0
Study: 35597252

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 149

Group type: COMPARATOR
Intervention: Best available therapy
Number of subjects: 149
Study: 34051350

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher intensity exercise
Number of subjects: 0
Study: 33484075

Group type: EXPERIMENTAL
Intervention: Adiponectin (ADPN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: eGFR
Number of subjects: 0
Study: 32112668

Group type: EXPERIMENTAL
Intervention: Bovine jugular vein valved xenograft (BJV)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) tube
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 206
Study: 34438091

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate closure (CAC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Surgical stripping (SS)
Number of subjects: 126
Study: 33665728

Group type: EXPERIMENTAL
Intervention: WM (bioequivalent formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GXR (reference product)
Number of subjects: 0